Here, we investigated the novel RNA-binding function of FSCN1 and found that FSCN1 inhibits protein tyrosine kinase 6 (PTK6) expression by binding to its pre-mRNA, thus facilitating tumor progression in ESCC. The gene discussed is FSCN1; the disease is neoplasm.